Coronavirus Update: To New & Existing Clients Learn More ›

FDA Cancer Warnings for Ranitidine (Zantac) Over NDMA Contamination

The United States Food and Drug Administration FDA Puts Out Warning for Ranitidine Users

In early April 2020, the U.S. Food and Drug Administration FDA warned that the over the counter heartburn medication Zantac ranitidine was unsafe. The FDA said this because all ranitidine products contain unacceptable levels of NDMA (N Nitrosodimethylamine NDMA).

When N Nitrosodimethylamine NDMA breaks down, ranitidine drugs can lead to cancer or probable human carcinogen if the levels of NDMA build up too much so you should talk to a health care professional about prescriptions and the FDA recall.

Brand name heartburn medications like Zantac ranitidines and other ranitidine medications are meant to treat gastroesophageal reflux disease (GERD), lower stomach acid, reduce coughing, and Yet, since this H2 blocker has too high levels of NDMA, the FDA has issued a recall to all patients for this OTC medication.

Talk to Our Experts about the Health Risks Associated with Over the Counter Zantac Ranitidine Medications

The FDA recall put patients and consumers about the risk of cancer and cancer consumer exposure with ranitidine drugs and ranitidine medications since drug manufacturers put NDMA in ranitidine. Many consumers and patients did not know this OTC heartburn med had too high level of NDMA or at least unacceptable levels.

Consumer exposure to unacceptable levels of NDMA in ranitidine or all ranitidine products can harm then seriously. If you have questions about ranitidine medications, the FDA market withdrawal request, NDMA human carcinogen, and the risk of cancer from ranitidine Zantac or other ranitidine products, talk to our ranitidine product experts about consumers rights regarding a faulty medication.

The following sections review the FDA warning of ranitidine medications.

What do Ranitidine Medicines Do and Why do Patients Take These Market Products?

Ranitidine medicines, including prescription ranitidine products, are known as H2 blockers. They lower the level of acid that your stomach produces.

This has a number of great benefits including the following:

  • Stop heartburn
  • Reduce coughing and swelling
  • Lower acid levels throughout your GI trct
  • Stop gastroesophageal reflux disease (GERD)

Unfortunately, drug evaluation and research, let by Janet Woodcock at the FDA and other health care professionals, have discovered that NDMA in the market product makes it unsafe even when kept in storage conditions at room temperature or higher than room temperatures. The low levels of NDMA can break down and develop into a probable human carcinogen.

The FDA Market Recall in 2020

As mentioned above, in early April 2020, Janet Woodcock of the FDA issued a warning that prompted this ranitidine product takeback to a drug take back location site. Specifically, it stated that when at normal or higher than room temperatures, low levels or just a low level of NDMA make it unsafe.

This FDA market pronouncement affected millions of people who take these drugs or products at low levels or beyond the intake limit. Understandably, they were concerned the OTC medications might cause cancer. It caused a dramatic reversal almost overnight.

Take Action by Bringing a Case

So far, there have been many lawsuits brought by individuals harmed due to this announcement. They are a part of the an MDL in Florida as well as a few class action lawsuits brought in Connecticut, New Jersey, and California. If you took these meds and were damaged, you should consider the same.

Plaintiffs that bring cases may be able to achieve different kinds of relief and compensation. First, you may obtain money back for the defective meds you bought.

Second, you may be able to recover nominal sums for the deficient warning that the pills had on the label.

Third, you could even possibly get damages for your pain, suffering, medical expenses, shortened lifespan, and cancer diagnosis.

To learn what you could receive in a possible jury award or settlement via a ranitidine lawsuit, talk to an attorney from our law firm today.

Rosenfeld Injury Lawyers LLC represents victims after they have been injured from defective pharmaceuticals. If you have taken these over the counter heartburn medications, let us know so we can see if we can help you. Lots of people are discovering that relief and compensation are available and it may be for you as well.

Our team of legal experts and attorneys work on contingency so you do not have to worry about any bill until you get a Zantac award or settlement. Start the process now by calling our offices and seeing what you need to do to get back on track.

Related Materials for Zantac Victims:

Sources Related to Ranitidine Recall and Cancer